Evercore ISI Group Downgrades Doximity to In-Line, Lowers Price Target to $25

Evercore ISI Group analyst Elizabeth Anderson downgrades Doximity (NYSE:DOCS) from Outperform to In-Line and lowers the price target from $30 to $25.